What does Genomic Health invest in?
Genomic Health invests most often at Series E and Series F (100% of the rounds on record), in sectors such as Energy Efficiency, Manufacturing and Biotechnology.

United States · Investor
Last cheque observed Oct 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietGrowth equity
2 rounds on record
Mostly Series E and Series F: 100% of its rounds
Every round we can evidence, newest first2 appearances
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as Genomic Health. A count of rooms they were both in, not a relationship either has claimed.
Genomic Health invests most often at Series E and Series F (100% of the rounds on record), in sectors such as Energy Efficiency, Manufacturing and Biotechnology.
2 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2014.
The median round it joins is $80M.
No investments in the last 12 months; the latest was in Oct 2014.
Most often Casdin Capital (2 rounds together), Genesys Capital (2 rounds together) and Randy Scott (2 rounds together).
Genomic Health is a growth equity firm based in Redwood City, United States.
Genomic Health was founded in 2000.
From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it